Doug Schenkel
Stock Analyst at Wolfe Research
(3.62)
# 845
Out of 4,996 analysts
68
Total ratings
54%
Success rate
34.5%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Upgrades: Outperform | $75 | $60.03 | +24.94% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $29.19 | +9.63% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $78.48 | -23.55% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $67.21 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $26.91 | +122.97% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $25.66 | +9.12% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $261.52 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $125.61 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.82 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $184.84 | +54.19% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $31.04 | - | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $123.39 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $43.90 | +17.31% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $11.72 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $91.69 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $53.57 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $464.24 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.70 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $84.06 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.21 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $11.84 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $162.97 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $291.71 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.13 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.73 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.09 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.01 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.27 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $9.50 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.46 | +631.71% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $12.00 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $318.00 | -71.70% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.19 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $204.65 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $67.10 | -76.15% | 2 | Sep 28, 2017 |
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $60.03
Upside: +24.94%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $29.19
Upside: +9.63%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $78.48
Upside: -23.55%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $67.21
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $26.91
Upside: +122.97%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $25.66
Upside: +9.12%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $261.52
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $125.61
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.82
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $184.84
Upside: +54.19%
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $31.04
Upside: -
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $123.39
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $43.90
Upside: +17.31%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $11.72
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $91.69
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $53.57
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $464.24
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $7.70
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $84.06
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.21
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $11.84
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $162.97
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $291.71
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.13
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.73
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.09
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $8.01
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.27
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $9.50
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.46
Upside: +631.71%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $12.00
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $318.00
Upside: -71.70%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.19
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $204.65
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $67.10
Upside: -76.15%